Try our Advanced Search for more refined results
August 28, 2020
Boehringer Ingelheim Pharmaceuticals Inc. et al v. Sun Pharmaceutical Industries Limited, et al
Case Number:
1:20-cv-01153
Court:
Nature of Suit:
Patent - Abbreviated New Drug Application(ANDA)
Judge:
Firms
Companies
- Boehringer Ingelheim Corp.
- Boehringer Ingelheim Vetmedica Inc.
- Lupin Ltd.
- Sun Pharmaceutical Industries Ltd.
Sectors & Industries:
View recent docket activity
Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.
Coverage
-
August 31, 2020
Boehringer Hits Sun Pharma With Suit Over Diabetes Generic
Boehringer Ingelheim has accused Sun Pharmaceutical of infringing its patents covering the Type 2 diabetes treatment Trijardy XR in a lawsuit in Delaware federal court.
Parties
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
- Direct access to case information and documents.
- All significant new filings across U.S. federal district courts, updated hourly on business days.
- Full-text searches on all patent complaints in federal courts.
- No-fee downloads of the complaints and so much more!
TRY LAW360 FREE FOR SEVEN DAYS
Already a subscriber? Click here to login